Equillium (EQ) Amortizatization of Intangibles (2019 - 2025)
Equillium's (EQ) quarterly Amortizatization of Intangibles came in at $14000.0 in Q1 2025, down 94.96% year-on-year from $278000.0 in Q1 2024, and down 79.71% on a QoQ basis from $69000.0 in Q4 2024.
Equillium (EQ) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Equillium (EQ) has 7 years of Amortizatization of Intangibles data on file, last reported at $14000.0 in Q1 2025.
- On a quarterly basis, Amortizatization of Intangibles fell 94.96% year-over-year to $14000.0 in Q1 2025; TTM through Dec 2025 was $14000.0, a 98.14% decrease from a year earlier, with the FY2025 full-year figure at $14000.0, down 98.14% from the prior year.
- Amortizatization of Intangibles for Q1 2025 stood at $14000.0, down from $69000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for EQ reached as high as $301000.0 in Q2 2023 and fell as low as -$105000.0 in Q2 2021.
- Historically, Amortizatization of Intangibles has averaged $73000.0 across 5 years, with a median of $14000.0 in 2025.
- Across the five-year window, Amortizatization of Intangibles tumbled 1528.57% in 2021 and soared 1257.69% in 2023, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$35000.0 in 2021, then soared by 31.43% to -$24000.0 in 2022, then surged by 787.5% to $165000.0 in 2023, then plunged by 58.18% to $69000.0 in 2024, then tumbled by 79.71% to $14000.0 in 2025.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $14000.0 in Q1 2025, $69000.0 in Q4 2024, and $166000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 278,000.00 |
| Mar 31, 2024 | 278,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Sep 30, 2023 | 152,000.00 |
| Sep 30, 2023 | 152,000.00 |
| Jun 30, 2023 | 301,000.00 |
| Jun 30, 2023 | 301,000.00 |
| Mar 31, 2023 | 296,000.00 |
| Mar 31, 2023 | 296,000.00 |
| Dec 31, 2022 | -24,000.00 |
| Dec 31, 2022 | -24,000.00 |